Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 25;12(2):299.
doi: 10.3390/diagnostics12020299.

Blood Levels of Indicators of Lower Respiratory Tract Damage in Chronic Bronchitis in Patients with Abdominal Obesity

Affiliations

Blood Levels of Indicators of Lower Respiratory Tract Damage in Chronic Bronchitis in Patients with Abdominal Obesity

Elena V Kashtanova et al. Diagnostics (Basel). .

Abstract

Objective: to study biomolecules associated with pathology in the respiratory system, in particular, with the development of chronic bronchitis in patients with abdominal obesity.

Materials and methods: This is a pilot study. The main group consisted of 158 people with chronic bronchitis, divided into two subgroups: one with abdominal obesity, and the other without it. The control group consisted of 68 people without chronic bronchitis. We determined the blood levels of SP-A, SP-D, α1-antitrypsin, CC16, PARC, and RELM-β.

Results: In the first subgroup, patients significantly more often complained of coughing, experienced shortness of breath 1.5 times more often with light physical exertion and 2.7 times more often with moderate physical exertion. In these patients, a Tiffeneau-Pinelli index (FEV1/FVC) below 70% was 1.8 times more common, more patients had FEV1 and FVC of less than 80%, and presented a statistically significant decrease in SP-A, α1-antitrypsin, CC16 levels and an increase in PARC levels than in the second subgroup.

Conclusion: In patients with chronic bronchitis and abdominal obesity, there is a decrease in the levels of SP-A, α1-antitrypsin, CC16 and an increase in the level of PARC compared with patients without abdominal obesity, which is probably due to the presence of an additional source of chronic inflammation associated with adipose tissue.

Keywords: CC16; PARC; RELM-β; SP-A; SP-D; abdominal obesity; chronic bronchitis; α1-antitrypsin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Level of the studied biochemical parameters in patients with chronic bronchitis with and without abdominal obesity.
Figure 1
Figure 1
Level of the studied biochemical parameters in patients with chronic bronchitis with and without abdominal obesity.

References

    1. Gan W.Q., Man S.F., Senthilselvan A., Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-analysis. Thorax. 2004;59:574–580. doi: 10.1136/thx.2003.019588. - DOI - PMC - PubMed
    1. Wouters E.F. Local and Systemic Inflammation in Chronic Obstructive Pulmonary Disease. Proc. Am. Thorac. Soc. 2005;2:26–33. doi: 10.1513/pats.200408-039MS. - DOI - PubMed
    1. Walter R.E., Wilk J.B., Larson M.G., Vasan R.S., Keaney J.F., Jr., Lipinska I., O’Connor G., Benjamin E. Systemic Inflammation and COPD: The Framingham Heart Study. Chest. 2008;133:19–25. doi: 10.1378/chest.07-0058. - DOI - PubMed
    1. Agusti A. Systemic Effects of Chronic Obstructive Pulmonary Disease: What We Know and What We Don’t Know (but Should) Proc. Am. Thorac. Soc. 2007;4:522–525. doi: 10.1513/pats.200701-004FM. - DOI - PubMed
    1. Sevenoaks M.J., Stockley R.A. Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity—A common inflammatory phenotype? Respir. Res. 2006;7:70. doi: 10.1186/1465-9921-7-70. - DOI - PMC - PubMed

Grants and funding

LinkOut - more resources